Home Combat Arthritis Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today

Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today

Jan 27, 2021 comments off

Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today

Investors are excited about the biotech’s clinical trial results.

Read More…

You May Also Like

9 COMMON ARTHRITIS MYTHS YOU SHOULDN’T BELIEVE

April the Giraffe Gets Bronze Statue, Ashes Spread in Memorial

Cartilage-inspired material may find use in self-lubricating bearings

Best Stocks To Invest In 2021? 4 Dividend Stocks To Watch

Why Exercise Can Be So Draining for People With Rheumatoid Arthritis

R&A plans tributes to mark 10-year anniversary of Ballesteros' death – Reuters